title: Plasma HVA in psychiatric patients: longitudinal studies.
abstract: Plasma homovanillic acid (pHVA) was measured in 40 inpatients (25 schizophrenic and 15 nonschizophrenic patients) who underwent up to 3 weeks of drug washout. Schizophrenic patients were then treated with trifluoperazine for 4 weeks, and weekly behavioral and pHVA measures were obtained. The baseline pHVA had no relationship to age, sex, washout period, diagnosis, or behavioral rating scores. In schizophrenic patients, the baseline pHVA did not differ significantly from any value obtained during 4 weeks of treatment. Although there was significant improvement in clinical symptoms, this was not related to changes in pHVA. Further, changes in any of the four Brief Psychiatric Rating Scale (BPRS) factors (i.e., positive symptoms, negative symptoms, hostility/suspicion, or anxiety/depression) were not correlated with changes in pHVA. Although other studies have reported a positive correlation between pHVA and psychotic symptoms, results of this study suggest that any observed relationship between pHVA and psychosis must be carefully interpreted.
authors.affiliation: Department of Psychiatry, University of Illinois, Chicago.
authors.forename: J I
authors.initials: JI
authors.lastname: Javaid
authors.forename: R P
authors.initials: RP
authors.lastname: Sharma
authors.forename: P G
authors.initials: PG
authors.lastname: Janicak
authors.forename: J M
authors.initials: JM
authors.lastname: Davis
mesh_terms: D006719:Homovanillic Acid / Q000097:blood*; D006801:Humans; D008137:Longitudinal Studies; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000097:blood* / Q000188:drug therapy; D012565:Schizophrenic Psychology; D014268:Trifluoperazine / Q000627:therapeutic use
chemical_list: D014268:Trifluoperazine; D006719:Homovanillic Acid